ACAD vs PEP · P/E 15, rev $576.0M vs P/E 22, rev $43.62B
ACADIA Pharmaceuticals Inc (ACAD) versus PepsiCo Inc (PEP) — a side-by-side from cached financials, not a winner call.
ACADIA Pharmaceuticals Inc (ACAD) is a biotechnology company listed on US.
PepsiCo Inc (PEP) is a beverages - non-alcoholic company listed on NASDAQ. It is led by Ramon Laguarta.
Latest reported ACAD revenue for 2026-06-30 was $576.0M. Net income was $35.1M. ACAD currently screens at market cap $3.51B and trailing P/E 15.3.
Latest reported PEP revenue for 2026-06-13 was $43.62B. Net income was $5.31B. PEP currently screens at market cap $193.55B and trailing P/E 22.2.
ACAD currently screens at market cap $3.51B and trailing P/E 15.3. PEP currently screens at market cap $193.55B and trailing P/E 22.2.
Not investment advice. Open the ACAD and PEP stock pages for the full models.
Not investment advice.